TraffikGene receives €2.5M from European Innovation Council to bring its technology to market

by Centro Singular de Investigación en Química Biológica y Materiales Moleculares

The project led by Prof. Javier Montenegro, principal investigator at CiQUS (USC), receives support from the European Innovation Council to advance in the preclinical validation of a novel delivery sy...

Read more

Light controlled drugs for future precision therapies against diseases such as cancer

by Institute for Advanced Chemistry of Catalonia (IQAC-CSIC)

Researchers from the Institute for Advanced Chemistry of Catalonia (IQAC) of Spanish National Research Council (CSIC) have developed a series of drugs, photosensitive molecules, which can be reversibl...

Read more

Lecanemab: una nueva puerta a la esperanza en el tratamiento del Alzheimer

by Fundación Pasqual Maragall

En la fase III de un ensayo clínico se verifican aspectos de seguridad y eficacia del fármaco en estudio. Si los resultados obtenidos en esta fase son suficientes y positivos, las agencias regulador...

Read more

AELIX Therapeutics presents positive results from randomized placebocontrolled phase IIa therapeutic HIV vaccine and immune modulator combination clinical trial

by Ysios Capital

The study evaluated the safety, tolerability, immunogenicity and efficacy of AELIX’s HTI T-cell therapeutic HIV vaccine in combination with Gilead’s investigational Toll-Like Receptor 7 (TLR7) ago...

Read more

Dos eventos desgranan los últimos avances en fotofarmacología para reducir lesiones cardiacas o restaurar la visión

by Institute for Advanced Chemistry of Catalonia (IQAC-CSIC)

La fotofarmacología se ha convertido en una de las áreas de la medicina actual con mayor potencial de crecimiento. Esta rama científica de reciente creación, que apenas cuenta con una decena de ...

Read more

INCLIVA realiza un trabajo de revisión de los tratamientos en desarrollo en la enfermedad rara distrofia miotónica tipo 1 (DM1) que muestra avances esperanzadores

by INCLIVA

Investigadores del Instituto de Investigación Sanitaria INCLIVA han realizado un trabajo de revisión de todos los tratamientos en desarrollo en la enfermedad rara distrofia miotónica tipo 1 (DM1) e...

Read more

CALYPSO: combined MET and PD-L1 inhibitation shows promise in a cohort of patients with MET-driven metastatic papillary renal cancer

by VHIO

Considering the observed tolerability of this combination and initial efficacy in patients with MET-driven tumors, this combined approach is now being tested in the randomised phase III SAMETA study.

Read more

3P Biopharmaceuticals increases its microbial production capacity with the installation of a 500 L fermenter

by 3P Biopharmaceuticals

3P Biopharmaceuticals (3P), a leading contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacturing for biological products complements its exis...

Read more

Spain’s first farm animal organoid biobank will be set up at the IRTA to allow research into infectious diseases without the use of live animals

by IRTA

Organic tissues will be recreated in miniature from pigs, chickens and ruminants and used during the different experimental phases to identify treatments and vaccines

Read more

3P Biopharmaceuticals avanza en su plan de expansión y adecuación de sus instalaciones

by 3P Biopharmaceuticals

3P Biopharmaceuticals (3P), organización líder especializada en el desarrollo de procesos cGMP y fabricación de medicamentos biológicos (CDMO) estrena su tercera instalación en el polígono Mocho...

Read more

What is meant by Off-label

by GENESIS Biomed

Off-label medicines, which are those prescribed under conditions other than those authorized in their SmPC, and therefore not covered by the regulatory agency for commercialization for that purpose, b...

Read more

Am-Pharma to present data from phase 3 revival study at upcoming scientific conferences

by Ysios Capital

AM-Pharma B.V. today announced that Professor Peter Pickkers, M.D., Ph.D., principal investigator of the Phase 3 REVIVAL study, will present data from the study at two upcoming scientific conferences....

Read more
Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Un ensayo de microscopía dinámica del ...

by CSIC - Centro Superior de Investigaciones Científicas

La revista ‘Nature Protocols’ selecciona esta técnica como “pro...

Photos Stream